Fridge-free tetanus-diphtheria vaccine passes first human trial
The world’s first fridge-free vaccine has produced encouraging Phase I results, offering a potential route to reducing the number of vaccines lost each year globally to cold-chain failures during storage and transport. SPVX02, a reformulated tetanus-diphtheria (Td) vaccine developed by UK biotech Stablepharma, was tested in a randomised Phase I trial involving 60 healthy adults…